Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alto Neuroscience, Inc. | Director | Stock Option (right to buy) | 25.2K | $80K | $3.17 | Jan 2, 2025 | Direct |
Alto Neuroscience, Inc. | Director | Common Stock | 716K | Feb 6, 2024 | By Lightswitch Capital Fund I, L.P. | ||
Newsmax Inc. | Director | Option (Right to Buy) | 17.5K | Mar 28, 2025 | Direct | ||
Alto Neuroscience, Inc. | Director | Series B Preferred Stock | 0 | Feb 6, 2024 | By Lightswitch Capital Fund I, L.P. | ||
Alto Neuroscience, Inc. | Director | Series C Preferred Stock | 0 | Feb 6, 2024 | By Lightswitch Capital Fund I, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NMAX | Newsmax Inc. | Mar 28, 2025 | 1 | $0 | 4 | Apr 4, 2025 | Director |
NMAX | Newsmax Inc. | Mar 28, 2025 | 0 | $0 | 3 | Mar 28, 2025 | Director |
ANRO | Alto Neuroscience, Inc. | Jan 2, 2025 | 1 | $80K | 4 | Jan 6, 2025 | Director |
ANRO | Alto Neuroscience, Inc. | Feb 6, 2024 | 4 | $0 | 4 | Feb 7, 2024 | Director |
ANRO | Alto Neuroscience, Inc. | Feb 1, 2024 | 2 | $54.9K | 4 | Feb 5, 2024 | Director |
ANRO | Alto Neuroscience, Inc. | Feb 1, 2024 | 0 | $0 | 3 | Feb 1, 2024 | Director |